Background
Uretsky, Barry Frederick was born on September 13, 1946 in Atlantic City, New Jersey, United States.
- Photos
- Works
- Photos
- Works
Barry Frederick Uretsky
Edit ProfileEducation
Bachelor in Religion, Wesleyan University, 1968; Doctor of Medicine, Temple University, 1972.
Career
Intern in internal medicine, Boston City Hospital, 1972-1973;
junior assistant resident, Boston City Hospital, 1973-1974;
clinical instructor medicine School Medicine, Boston University, 1974-1975;
staff physician, Norwood Hospital, 1976-1979;
clinical instructor medicine Medical School, Harvard University, 1976-1979;
assistant professor medicine School Medicine, U. Pittsburgh, 1979-1985;
associate professor with tenure, U. Pittsburgh, 1985-1995;
co-director cardiac catheterization laboratories, Prebyn. University Hospital, Pittsburgh, 1979-1994;
director heart transplant service, Prebyn. University Hospital, Pittsburgh, 1988-1991;
director heart failure unit, Prebyn.
University Hospital, Pittsburgh, 1988-1994;
director cardiac catheterization laboratories, Westmoreland Regional Hospital, Greensburg, Pennsylvania, 1994-1995;
director cardiac catheterization laboratories, University Texas Medical Branch, Galveston, since 1995. 1st year fellow cardiology Boston City Hospital, 1974-1975. 2d year fellow cardiology Boston University Medical Center, 1978-1979.
Achievements
Membership
Fellow American College Cardiology, Council Clinical Cardiology, Society Cardiac Angiography and Interventions. Member American Heart Association, American Federation Clinical Research, American Society Hypertension, International Society Heart Transplantation, Heart Failure Society American, Inc., Western Pennsylvania Heart Association (grantee 1981-1982, 84-85, grantee Women's auxiliary 83-84), Phi Beta Kappa, Babcock Surg.Soc., Alpha Omega Alpha.
Connections
M. Sybil Uretsky.
-
Born
-
Nationality
American
Awards
-
Grantee Pfizer Inc., 1980-1982, 93-94, Merrell Dow Pharmaceuticals, Inc., 1982-1983, 82-87, 83-84, 83-87, Sterling Drug, Inc., 1984-1985, Parke-Davis Research Institute, 1984-1986, 85-86, Sandoz Research Laboratory, 1986-1987, Mellon Competitive Fund secretion, 1986-1987, Chemical Industries Basel-GEIGY Pharmaceuticals, 1986-1987, Wyeth laboratories, 1987-1988, National Institutes of Health, 1988-1990, Molecular Delivery Corporation Study Group, 1988-1991, Smith Kline laboratories, 1988-1989, Burroughs Wellcome, 1989-1990, 90-91, 91-92, 93, Zambon laboratories, 1989-1990, Kensey-Nash Corporation, 1990-1991, Otsuka Pharmaceuticals, 1990-1991, 92-93, 93, 93-94, Marion Merrell Dow, 1991-1992, Merck Research Labs, 1992, 92-93, Zeneca Pharmaceuticals, 1993-1995, Hoechst Pharmaceuticals, 1993-1994, SmithKline Beecham Beecham, 1993, The Cleveland Clinic Foundation, 1996.Grantee Pfizer Inc., 1980-1982, 93-94, Merrell Dow Pharmaceuticals, Inc., 1982-1983, 82-87, 83-84, 83-87, Sterling Drug, Inc., 1984-1985, Parke-Davis Research Institute, 1984-1986, 85-86, Sandoz Research Laboratory, 1986-1987, Mellon Competitive Fund secretion, 1986-1987, Chemical Industries Basel-GEIGY Pharmaceuticals, 1986-1987, Wyeth laboratories, 1987-1988, National Institutes of Health, 1988-1990, Molecular Delivery Corporation Study Group, 1988-1991, Smith Kline laboratories, 1988-1989, Burroughs Wellcome, 1989-1990, 90-91, 91-92, 93, Zambon laboratories, 1989-1990, Kensey-Nash Corporation, 1990-1991, Otsuka Pharmaceuticals, 1990-1991, 92-93, 93, 93-94, Marion Merrell Dow, 1991-1992, Merck Research Labs, 1992, 92-93, Zeneca Pharmaceuticals, 1993-1995, Hoechst Pharmaceuticals, 1993-1994, SmithKline Beecham Beecham, 1993, The Cleveland Clinic Foundation, 1996.